Gu Jinying, He Yanyi, He Chenxi, Zhang Qiuyue, Huang Qifei, Bai Shangjun, Wang Ruoning, You Qidong, Wang Lei
State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China.
Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
Signal Transduct Target Ther. 2025 Mar 12;10(1):84. doi: 10.1038/s41392-025-02166-2.
Molecular chaperones, a class of complex client regulatory systems, play significant roles in the prevention of protein misfolding and abnormal aggregation, the modulation of protein homeostasis, and the protection of cells from damage under constantly changing environmental conditions. As the understanding of the biological mechanisms of molecular chaperones has increased, their link with the occurrence and progression of disease has suggested that these proteins are promising targets for therapeutic intervention, drawing intensive interest. Here, we review recent advances in determining the structures of molecular chaperones and heat shock protein 90 (HSP90) chaperone system complexes. We also describe the features of molecular chaperones and shed light on the complicated regulatory mechanism that operates through interactions with various co-chaperones in molecular chaperone cycles. In addition, how molecular chaperones affect diseases by regulating pathogenic proteins has been thoroughly analyzed. Furthermore, we focus on molecular chaperones to systematically discuss recent clinical advances and various drug design strategies in the preclinical stage. Recent studies have identified a variety of novel regulatory strategies targeting molecular chaperone systems with compounds that act through different mechanisms from those of traditional inhibitors. Therefore, as more novel design strategies are developed, targeting molecular chaperones will significantly contribute to the discovery of new potential drugs.
分子伴侣是一类复杂的客户调节系统,在防止蛋白质错误折叠和异常聚集、调节蛋白质稳态以及在不断变化的环境条件下保护细胞免受损伤方面发挥着重要作用。随着对分子伴侣生物学机制的理解不断深入,它们与疾病发生和发展的联系表明这些蛋白质是有前景的治疗干预靶点,引发了广泛关注。在此,我们综述了确定分子伴侣和热休克蛋白90(HSP90)伴侣系统复合物结构的最新进展。我们还描述了分子伴侣的特征,并阐明了在分子伴侣循环中通过与各种共伴侣相互作用起作用的复杂调节机制。此外,还深入分析了分子伴侣如何通过调节致病蛋白影响疾病。此外,我们聚焦于分子伴侣,系统地讨论了临床最新进展以及临床前阶段的各种药物设计策略。最近的研究已经确定了多种针对分子伴侣系统的新型调节策略,这些化合物的作用机制与传统抑制剂不同。因此,随着更多新型设计策略的开发,靶向分子伴侣将对发现新的潜在药物做出重大贡献。